US Patent Issued to Amgen on June 2 for "Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles" (Washington, California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,938, issued on June 2, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles" was invented by Zhimei Du (Bellevue, Wash.), Pranhitha Reddy (Seattle), Randal B. Bass (Seattle), Feng He (Lynnwood, Wash.), William C. Fanslow III (Normandy Park, Wash.), Yuling Zhang (Bellevue, Wash.), Da Ren (Thousand Oaks, Calif.) and Randall R. Ketchem (Snohomish, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to variant Fc-containing molecules, such as antibodies and Fc-fusion molecules, having glycosylation characteristics favorable to la...